Exalt Medicament Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Exalt Medicament
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Debasis Roy and Chhanda Roy serve as directors at the Company.
- CIN/LLPIN
U85100WB2004PTC098827
- Company No.
098827
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Exalt Medicament Private Limited offer?
Exalt Medicament Private Limited offers a wide range of products and services, including Hotel Booking & Reservation Services, Hotel Bookings, Pharmaceutical Capsules, Waste Tyre Recycle Plant.
Who are the key members and board of directors at Exalt Medicament?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debasis Roy  | Director | 11-Jun-2004 | Current |
| Chhanda Roy | Director | 11-Jun-2004 | Current |
Financial Performance of Exalt Medicament.
Exalt Medicament Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Exalt Medicament?
In 2016, Exalt Medicament had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Exalt Services Private LimitedActive 23 years 6 monthsDebasis Roy and Chhanda Roy are mutual person
- Exalt Surveyors Private LimitedActive 19 years 10 months
Debasis Roy and Chhanda Roy are mutual person
- Exalt Infra-Nirmaan Private LimitedActive 13 years 1 month
Debasis Roy and Chhanda Roy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Exalt Medicament?
Unlock and access historical data on people associated with Exalt Medicament, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exalt Medicament, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exalt Medicament's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
